<DOC>
	<DOCNO>NCT01427192</DOCNO>
	<brief_summary>The purpose study study differential short-term effect nocturnal oxygen , acetazolamide tablet nocturnal non-invasive positive pressure ventilation symptom , exercise capacity nocturnal breathing disturbance subject pulmonary hypertension sleep relate breathe disorder - Trial medicinal product</brief_summary>
	<brief_title>Treatment Sleep Related Breathing Disorders Patients With Pulmonary Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<mesh_term>Respiratory Aspiration</mesh_term>
	<mesh_term>Sleep Wake Disorders</mesh_term>
	<mesh_term>Parasomnias</mesh_term>
	<mesh_term>Acetazolamide</mesh_term>
	<criteria>Inclusion criterion : percapillary pulmonary hypertension diagnose right heart catheterisation stable therapy clinical condition least 4 week sleep disorder breathe apnea/hypopnea index &gt; 10 events/h and/or median nocturnal oxygen saturation &lt; 90 % Exclusion criterion : Pregnancy severe daytime hypoxemia ( PaO2 &lt; 7.2 kPA ) patient predominantly obstructive sleep apnea .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Breathing-Related Sleep Disorder</keyword>
	<keyword>Pulmonary Hypertension</keyword>
</DOC>